2015 BDSRA Conference and Hotel Reservations

10923460_886590218047391_241766103610793704_oVisit our 2015 BDSRA Conference page on Facebook.

Hotel reservations are now available for the 2015 Annual Family Conference. This year it will be at the Eaglewood Spa and Resort in Itasca IL, July 9-12. We strongly suggest that if you are flying, that you land at O’Hare International Airport. Please call the hotel directly to reserve your room, and if you will have a wheelchair let them know, we have made special arrangements with the hotel. Be sure to mention “Batten Disease” or “BDSRA” to get the discounted rate of $107 per night. Reservations must be made by June 15th. The phone number is 877-285-6150, and their website is http://www.eaglewoodresort.com/ Conference registration will be available the beginning of March. As always, please contact us if you have any questions, tkirby@bdsra.org or 614-973-6013. We look forward to seeing everyone in July.
(Read More)

Conference Online Registration is Now Open

Conference Online Registration is Now OpenWe are looking forward to seeing every in Chicago, Illinois, this July.   The conference is Thursday, July 9th to Sunday, July 12th, 2015. Click here to register for the BDSRA conference: http://bdsra.org/product/2015-conference Conference registration will be open until June 15th, 2015. Hotel registration for conference at Eaglewood Resort and Spa (www.eaglewoodresort.com) is open until June 15th, 2015. Please call the hotel directly at 877-285-6150 to reserve your room, and if you will have a wheelchair let them know, we have made special arrangements with the hotel. Be sure to mention “Batten Disease” or “BDSRA” to get the discounted rate of $107 per night. We strongly suggest that if you are flying, that you land at O’Hare International Airport. Canadian chapter members may be eligible for stipends and should contact bevmaxim@yahoo.ca before registering. If you would like information about BDSRA stipends, or have any questions please contact us at tkirby@bdsra.org or 614-973-6013.
(Read More)

CLN2 Enzyme Replacement Trial Opens First US Site

BDSRAWe are very happy to announce that the first United States site for the BioMarin CLN2 enzyme replacement study has been listed on clinicaltrials.gov. Dr. Emily De los Reyes at Nationwide Children’s Hospital in Columbus and her co-PI, Dr. Lenore Leowald are currently assessing children to begin the study in December. To learn more about the official guidance, and criteria, go to http://1.usa.gov/1Hr3IbI.  Tracy VanHoutan, Lance Johnston, researchers from universities all over the world and BioMarin have made this important advancement for families and children with our utmost thanks!
(Read More)

Charlee Nelson Inspires Utah Legislation Named in Her Honor

The little girl who loved to sing, dance, and sing Twinkle, Twinkle Little Star was able to put a face on what it really meant to need a medical miracle, her mother said, which was her greatest gift for so many others facing severe seizure-inducing conditions.

Nelson familyFor Catrina and Jeff Nelson, losing their 6-year-old daughter Charlee on March 15, 2014, to late infantile Batten disease has been like a bad dream.  In the midst of their grief, the family stood in the private office of Utah Governor Gary Herbert the next day as Herbert signed “Charlee’s Law,” in a quiet ceremony.  Also known as HB 105, Charlee’s Law will allow those with intractable epilepsy to first acquire written permission from a neurologist and then apply for a waiver to import cannabis oil.  The Utah Legislature formally passed the bill March 13, 2014 after Charlee and her parents arrived on the floor of the House and Senate to witness the vote. According to Catrina and Jeff, Charlee held on until the legislation was passed after many weeks of severely declining health and complications.  After battling mononucleosis in October and surgery for a feeding tube, their daughter’s strength slowly diminished.  
(Read More)

International Partners Advance Batten Disease Research Targets

150x150BDSRA, in collaboration with international and family foundation partners,
has announced grants totaling $408,000 to advance research in Batten disease.      International Funding Partners Advance Batten Disease Research Targets   COLUMBUS, OHIO (April 24, 2014)  The Batten Disease Support and Research Association (BDSRA), in collaboration with international and family foundation  partners, has announced grants totaling $408,000 to advance the development of treatments and cures for Batten disease. Co-funders BDSRA-Australia, the Batten Disease Family Association of the United Kingdom, Noah’s Hope, and Hope 4 Bridget joined with BDSRA to support projects that span the United States, the United Kingdom, Australia, and Germany.   Investigations to identify drug targets, drug discovery, and expand a patient registry have been funded through awards to six researchers:  David Palmer, PhD, Lincoln University of New Zealand; Stephan Storch, PhD, University Medical Center Hamburg-Eppendorf, Germany; Angela Schulz, PhD, University Medical Center Hamburg-Eppendorf, Germany; Jonathan Cooper, PhD, King’s College, London; Jeffery Gerst, PhD, Weizmann Institute of Science, Israel; and Erika Augustine, MD, the University of Rochester.
(Read More)

April 2014 Newsletter

April 2014 NewsletterBDSRA announces global research grants and programs in April Newsletter.  In collaboration with international and family foundation partners, BDSRA has awarded research grants for 2013 that span the U.S., Australia, Germany, and the United Kingdom.  Proposals were funded that focused on identifying drug targets and drug discovery, developing a patient registry, and expanding projects in the basic biology of Batten disease.  To read more details as well asnews about programs, conference, and families, go to April Newsletter
(Read More)

ourboys 5k/10k

ourboys 5k/10kourboys 5k/10k
April 12, 2014
8:30am
Harris Road Middle School
1251 Patriot Plantation Blvd
Concord NC 28027 Online Registration and more info at http://davidsontiming.com/2013/11/our-boys-5k-10k-2014/
 
(Read More)